Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pyruvate Kinase Deficiency Global Longitudinal Registry

NCT03481738 is registered in ClinicalTrials.gov with Agios Pharmaceuticals, Inc. as lead sponsor.

NCT NCT03481738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03481738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pyruvate Kinase Deficiency Global Longitudinal Registry
Lead sponsor
Agios Pharmaceuticals, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
April 23, 2018
Completion date
May 31, 2027
Enrollment
500 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

pyruvate kinase deficiency